Frontlight ResearchEarly access
CompletedNo phase
Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens
Key facts
- Who runs it
- Johnson & Johnson Surgical Vision, Inc.
- Where
- Bakersfield, Brecksville, Garden City, Houston, Jacksonville, San Antonio, Sioux City, and Sioux Falls, United StatesSee the 9 sites
- Trial code
- Status
- Completed
- People taking part
- 245 people enrolled
- Started
- 3 Jun 2024
- Ended
- 23 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Test IOL Model DEN00V
- Control IOL Model DCB00
- Record updated
- 24 August 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- To be considered for enrollment in this study, patient must:
- be at least 22 years old
- have cataracts in both eyes
- sign the written informed consent
- be willing and able to comply with examination procedures
- understand, read and write English to complete informed consent and questionnaires
- be available for study follow-up visits EXCLUSION CRITERIA; Patient will not be eligible to take part in the study if:
- currently participating in any other clinical study or have participated in a clinical study during the last 30 days
- have a certain disease/illness, such as poorly controlled diabetes
- have certain ocular conditions, such as uncontrolled pressure in the eye
- taking medication that may affect vision
- pregnant, plan to become pregnant during the study, or are breastfeeding
Where in United States
- Empire Eye & Laser CenterBakersfield, United States
- Cleveland Eye ClinicBrecksville, United States
- OCLI VisionGarden City, United States
- Berkeley Eye InstituteHouston, United States
- Whitsett Vision GroupHouston, United States
- Levenson Eye AssociatesJacksonville, United States
- Parkhurst NuVisionSan Antonio, United States
- Jones Eye CenterSioux City, United States
- Vance Thompson VisionSioux Falls, United States
About the trial
What the trial wants to find out
Prospective, multicenter, bilateral, interventional, controlled, masked (sponsor, subjects, and evaluators), randomized clinical trial.
The 2 groups in the trial
- Test IOLTreatment being tested
DEN00V
Treatment: Test IOL Model DEN00V
- Control IOLExisting treatment, for comparison
DCB00
Treatment: Control IOL Model DCB00
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 August 2026